Nivel bajo de azcar en la sangre (hipoglucemia)
Glucagon-like peptide-1 (GLP-1) receptor agonists are injectable medications prescribed for different indications: some for the management of type 2 diabetes mellitus (such as Ozempic, Victoza, Trulicity), and others specifically for weight management in adults with obesity or overweight with comorbidities (such as Wegovy, Saxenda)
This article examines the evidence for lipid-modifying effects, identifies who may benefit, and clarifies how GLP-1 agents compare with traditional cholesterol-lowering treatments within UK clinical practice
GLP-1RAs are generally well tolerated
Second Nature has worked with the NHS since 2017, combining weight-loss medication with structured habit support from registered dietitians to help the weight loss last
Those who have used or are currently using these drugs have a direct understanding of their effects on appetite suppression and food consumption, making them more attuned to the potential downstream consequences for food-related businesses